Bio-Techne

Bio-Techne

Quarterly Financials

Values in thousands2026-06-302026-03-312025-12-312025-09-30
Revenue
$321,192
$311,415
$295,877
$286,555
Gross Profit
211,394
208,288
191,277
188,112
EBITDA
91,899
98,616
77,664
75,265
EBIT
67,758
74,447
52,955
50,925
Net Income
54,611
51,057
38,009
38,185
Net Change In Cash
321,192
311,415
295,877
286,555
Free Cash Flow
86,936
77,575
76,490
22,222
Cash
264,712
209,819
172,879
144,962
Basic Shares
157,009
156,943
156,999
156,362

Annual Financials

Values in thousands2026-06-302025-06-302024-06-302023-06-30
Revenue
$1,215,039
$1,219,635
$1,159,060
$1,136,702
Gross Profit
799,071
790,272
769,725
769,815
EBITDA
343,444
216,875
313,136
457,112
EBIT
246,085
106,972
201,425
349,874
Net Income
181,862
73,400
168,105
285,263
Net Change In Cash
1,215,039
1,219,635
1,159,060
1,136,702
Cost of Revenue
11,360
Free Cash Flow
263,223
256,550
236,104
216,149
Cash
264,712
162,186
151,791
180,571
Basic Shares
157,009
159,717
160,774
161,855

Earnings Calls

QuarterEPS
2026-06-30
$0.49
2026-03-31
$0.53
2025-12-31
$0.46
2025-09-30
$0.36